208 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
200
FS-21-Film (d)
Further Session
13:30– 16:00
|
Hall London 3
TOPIC 28:
History, art and cultural sciences
Nebel im August
Chair:
Michael von Cranach, Germany
KN-31
Keynote Lecture
15:15– 16:15
|
Hall A6 /A7
TOPIC 35:
Psychiatry and society
Psychiatrists as partners for change in global
mental health
Chairs:
Iris Hauth, Germany
Mario Maj, Italy
Speaker:
Helen Herrman, Australia
KN-32 (d)
Keynote Lecture
15:15– 16:15
|
Hall A8
TOPIC 10:
Gerontopsychiatry
Kognitives Altern: Möglichkeiten und Herausfor-
derungen
Chairs:
Andreas Meyer-Lindenberg, Germany
Andreas J. Fallgatter, Germany
Speaker:
Ursula M. Staudinger, USA
KN-33
Keynote Lecture
15:15– 16:15
|
Hall A4
TOPIC 36:
Social determinants of mental health
Accelerated globalization and mental health
Chairs:
Dinesh Bhugra, United Kingdom
Hans-Jürgen Möller, Germany
Speaker:
Driss Moussaoui, Morocco
SP-06
Special Session
15:15– 16:15
|
Room M2 /M3
TOPIC 18:
Pharmacotherapy
Future perspectives of pharmacotherapy
Chairs:
Berend Malchow, Germany
Franziska Baessler, Germany
Speaker:
Isabella Heuser, Germany
ST-23
State-of-the-Art-Symposium
15:15– 16:45
|
Hall A3
TOPIC 3:
Psychotic disorders
Psychotic disorders
Chairs:
Peter Falkai, Germany
Christoph Correll, USA
001
Non-pharmacological interventions in schizo-
phrenia: state-of-the-art and further directions
Peter Falkai, Germany
002
Pharmacotherapy for people with schizophrenia:
weighing the options
Christoph Correll, USA
ST-24 (d)
State-of-the-Art-Symposium
15:15– 16:45
|
Hall A2
TOPIC 31:
Suicide and psychiatric emergencies
Suizidalität
Chairs:
Ulrich Hegerl, Germany
Manfred Wolfersdorf, Germany
001
Epidemiologie: Verursachung und neueste
Trends
Ulrich Hegerl, Germany
002
Risikoeinschätzung und klinisches Management
Manfred Wolfersdorf, Germany
S-303
Symposium
15:15– 16:45
|
Hall A1
TOPIC 14:
Neurobiology and genetics
Genetic prediction of antipsychotic response and
side effects of Clozapine
Chairs:
Dan Rujescu, Germany
James Walters, United Kingdom
001
Pharmacogenomics of treatment resistant
schizophrenia
James Walters, United Kingdom
002
Pharmacogenomics of agranulocytosis and
neutropenia
Dan Rujescu, Germany
003
Longitudinal epigenetic changes associated
with Clozapine use
Amy Gillespie, United Kingdom
004
Clozapine use in Iceland and the risk of
neutropenia and type 2 diabetes
Oddur Ingimarsson, Iceland
Magnús Haraldsson, Halldóra Jónsdóttir, Engilbert
Sigurðsson, James H. MacCabe